Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
12 hedge funds and large institutions have $65.3M invested in Amryt Pharma plc American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
8.28% more ownership
Funds ownership: 0% → 8.28% (+8.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
+$26.6M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$8.86M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.3M |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$7.83M |
| 5 |
AC
Armistice Capital
New York
|
+$3.54M |
Top Sellers
AMYT Hedge Fund Activity: Q3 2020 in Review
12 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q3 2020, worth a combined $65.3M.
Buyers outnumbered sellers: 12 funds opened new AMYT positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was EdgePoint Investment Group, opening a new position worth an estimated $26.6M.
- 12 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $65.3M of Amryt Pharma plc American Depositary Shares stock for Q3 2020.
- 12 funds opened new Amryt Pharma plc American Depositary Shares positions in Q3 2020 and 0 closed out, a net change of +12 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q3 2020 was EdgePoint Investment Group, an estimated $26.6M added.
Based on aggregated 13F filings for Q3 2020.